Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
October 27, 2025- ( Investorideas.com Newswire), a go-to investing platform covering biotech and medtech stocks releases a ...
The Cancer Molecular Diagnostics market is seeing accelerated growth driven by trends like personalized medicine, pharmacogenomics, and liquid biopsy. Key opportunities lie in companion diagnostics, ...
Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of ...
Antimicrobial resistance (AMR) represents one of the most pressing global health challenges of the 21st century, threatening the effectiveness of treatments and burdening healthcare systems worldwide.
Breast cancer detection has evolved from microscopes to molecular precision to offer diagnostic insights: Expert: Shardul Nautiyal, Mumbai Saturday, November 1, 2025, 08:00 Hrs [I ...
The Chosun Ilbo on MSN
18th Gochon Award Goes to Molbio Diagnostics
The Jongkuntang Gochon Foundation announced that it has awarded the 18th Gochon Award to Molbio Diagnostics, a molecular ...
An important scientific study published in The Lancet shows the strong public health impact of deploying molecular diagnostics closer to the people.
Molbio Diagnostics receives the prestigious Kochon Prize for its innovative Truenat portable PCR system, transforming ...
Roche’s diagnostics business continues to be buffeted by China headwinds, but the Swiss major believes it has enough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback